Geode Capital Management LLC raised its holdings in Chemed Co. (NYSE:CHE – Free Report) by 1.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 340,409 shares of the company’s stock after purchasing an additional 4,966 shares during the period. Geode Capital Management LLC’s holdings in Chemed were worth $180,654,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. UMB Bank n.a. increased its stake in Chemed by 300.0% in the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock valued at $28,000 after acquiring an additional 39 shares during the period. Atala Financial Inc bought a new stake in shares of Chemed in the 4th quarter valued at approximately $29,000. CBIZ Investment Advisory Services LLC raised its holdings in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after buying an additional 22 shares in the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed during the 4th quarter worth approximately $34,000. Finally, Tortoise Investment Management LLC boosted its stake in Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after buying an additional 34 shares in the last quarter. 95.85% of the stock is owned by institutional investors.
Insider Activity at Chemed
In other Chemed news, CEO Kevin J. Mcnamara sold 1,000 shares of the firm’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares in the company, valued at approximately $62,566,139.07. This trade represents a 0.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 3.32% of the stock is currently owned by company insiders.
Chemed Price Performance
Chemed Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were paid a $0.50 dividend. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.33%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.
Wall Street Analyst Weigh In
Several research analysts have issued reports on the company. Royal Bank of Canada increased their price objective on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th.
View Our Latest Analysis on Chemed
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- 5 Top Rated Dividend Stocks to Consider
- Newsmax’s IPO Whiplash: Meme Stock Hype or Growth Potential?
- How Investors Can Find the Best Cheap Dividend Stocks
- Disney 2025 Shareholders: Major Updates for Investors
- Most Volatile Stocks, What Investors Need to Know
- Advance Auto Parts Stock: A Classic Rebound Play in the Making
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.